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Abstract 
Retinitis Pigmentosa (RP) is a group of progressive inherited retinal dystrophies that cause 
visual impairment as a result of photoreceptor cell death. RP is heterogeneous, both clinically 
and genetically making difficult to establish precise genotype-phenotype correlations. In a 
Spanish family with autosomal recessive RP (arRP), homozygosity mapping and whole exome 
sequencing led to the identification of a homozygous mutation (c.358_359delGT; 
p.Ala122Leufs*2) in the ZNF408 gene. A screening performed in 217 additional unrelated 
families revealed another homozygous mutation (c.1621C>T; p.Arg541Cys) in an isolated RP 
case. ZNF408 encodes a transcription factor that harbors ten predicted C2H2-type fingers 
thought to be implicated in DNA binding. To elucidate the ZNF408 role in the retina and the 
pathogenesis of these mutations we have performed different functional studies. By 
immunohistochemical analysis in healthy human retina, we identified that ZNF408 is expressed 
in both cone and rod photoreceptors, in a specific type of amacrine and ganglion cells, and in 
retinal blood vessels. ZNF408 revealed a cytoplasmic localization and a nuclear distribution in 
areas corresponding with the euchromatin fraction. Immunolocalization studies showed a partial 
mislocalization of the p.Arg541Cys mutant protein retaining part of the WT protein in the 
cytoplasm. Our study demonstrates that ZNF408, previously associated with Familial Exudative 
Vitreoretinopathy (FEVR), is a new gene causing arRP with vitreous condensations supporting 
the evidence that this protein plays additional functions into the human retina. 
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Introduction 
Retinitis Pigmentosa (RP [MIM number 268000]) is the most common manifestation of 
inherited retinal dystrophy, with a worldwide prevalence of 1:4,000 approximately (1). It is 
characterized by a progressive degeneration of rod photoreceptors, leading to night blindness 
and constriction of the visual field, followed by the degeneration of cone photoreceptors, 
resulting in a total loss of vision. 
There is a large variability in the age of onset, progression, retinal appearance and final visual 
outcome (2). RP is inherited in all Mendelian forms: autosomal dominant (20% of the cases), 
autosomal recessive (30%) or X-linked trait (10%). Approximately 40% of patients with RP 
represent isolated cases; the percentage varies among different populations (3, 4). Non-
Mendelian inheritance patterns such as digenic, mitochondrial or de novo mutations have been 
reported, accounting for a small proportion of cases (2). 
To date, more than 70 genes have been associated with RP, being heterogeneous, both clinically 
and genetically. However, mutations in these genes account for the disease in little over half of 
all patients thus, remaining genes yet to be identified (4, 5). Although the function of some of 
these genes have been extensively studied, it is difficult to establish a precise genotype-
phenotype correlation because mutations in different RP genes can cause overlapping clinical 
phenotypes (6). 
The ZNF408 gene encodes a zinc finger protein of 720 amino acids that is predicted to harbor 
ten C2H2-type finger binding domains thought to be implicated in DNA binding. 
Recently, in a large Dutch family, a heterozygous missense p.His455Tyr variant in ZNF408 has 
been associated to Familial Exudative Vitreoretinopathy (FEVR [MIM number 133780]), a 
disorder affecting the growth and development of blood vessels in the retina (7). 
Interestingly, in this study novel homozygous mutations in the ZNF408 gene have been 
identified in two unrelated Spanish families as cause of RP. These findings support the 
hypothesis that different mutations, either in heterozygous or homozygous state, produce 
completely different phenotypes and suggest that ZNF408 may play additional roles apart from 
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its implication in vasculature development. In this context, this is the first time the expression 
and cellular distribution of ZNF408 have been studied in the human retina. 
Results 
Selected family and summary of the studies performed 
Two affected siblings (II:1 and II:2) of a Spanish family (RP-0322), whose parents came from 
the same and small geographic region (Figure 1A), were diagnosed with autosomal recessive 
RP (arRP). In order to identify the genetic cause underlying the arRP within the family, first we 
performed whole genome homozygosity mapping using high resolution SNP-array and further 
whole-exome sequencing (WES) analysis. A previous genotyping study for the index case (II:2) 
allowed discarding known mutations associated with arRP. Also, direct Sanger sequencing of 
the coding exons and flanking intronic sequences of EYS did not detect any mutated allele (8). 
Genetic Analysis 
Homozygosity mapping and Whole-Exome Sequencing (WES) Analysis. Whole genome 
homozygosity mapping in II:1 and II:2 of RP-0322 family was performed. The two affected 
siblings shared four homozygous regions ranging from 2.6 to 1.8 Mb (Table 1). These regions 
contain a total of 193 genes, none of which were previously associated with Retinal Dystrophies 
(RD). 
Subsequently, the index case (II:2) of RP-0322 family was analysed by WES. A total of 
88,299,239 reads were uniquely mapped to exonic regions with a median of coverage of 59X 
(mean coverage 69.5X).  
After excluding those variants present in non-coding regions and common variants with a minor 
allele frequency (MAF) <0.005 at dbSNP, 1000 genomes (1000g) or the Exome Variant Server 
(EVS) databases, we reduced the number of candidate variants underlying RP from 8,133 to 276 
(Table 2). Assuming an autosomal recessive inheritance pattern and taking into account a very 
likely common ancestry in the affected family, homozygous variants lying in the previously 
identified homozygous regions were prioritized (Table 2). Also, the expression in human retinal 
tissues was considered. With this criteria, only one likely pathogenic candidate variant remained, 
i.e. a frameshift variant in exon 3 of ZNF408 (NM_024741.2: c.358_359delGT; 
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p.Ala122Leufs*2) (Figure 1B). Due to its implication in vasculature development previously 
described and its expression in human retina, the ZNF408 gene was selected as a new candidate 
gene causing arRP. 
Sanger sequencing of the specific region confirmed the presence of this variant identified by 
WES (Figure 1A). This variant was not found in 374 ethnically control alleles nor in 1000g or 
EVS databases. 
Screening of the ZNF408 gene in an arRP Spanish cohort. Following this finding, and to 
determine the prevalence of the ZNF408 mutations as a potential cause of arRP, mutation 
analysis of the ZNF408 gene was performed by Sanger sequencing in 217 additional Spanish 
probands affected with sporadic and/or arRP. An additional ZNF408 variant (c.1621C>T; 
p.Arg541Cys) was found homozygously in a sporadic case from a consanguineous Spanish RP 
family (II:2, RP-0976, Figure 1A). This variant was not found in a total of 374 healthy control 
Spanish chromosomes and in SNP databases (1000g and EVS databases). The Arginine residue 
at position 541 is localized in the seventh of the ten zinc finger domain and is highly conserved 
across evolution (Figure 1B,C).  
Two other novel missense variants, p.Gly492Arg and p.Gln583Lys, were identified in 
heterozygous state in two other arRP patients. Both missense changes were not present in 75 in-
house exome datasets. These residues are highly conserved (Figure 1C). and in silico 
predictions of the pathogenicity of these two missense variants assessed both of them as 
deleterious (Table 3).  
In addition, a Comparative Genomic Hybridization array (aCGH) with an exonic coverage 
(Figure S1) was performed to discard large deletions and copy number variations (CNVs) in the 
ZNF408 locus in both patients. No second allele was found in these two patients.  
The variants p.Gly492Arg and p.Gln583Lys are highly conserved across the evolution (Figure 
1C) , rendering it possible that these variants affect ZNF408 protein function but are not 
responsible for the phenotype in these particular patients. 
Ophthalmic examination 
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The age of onset in all affected individuals (II:1 and II:2, RP-0322 and II:2, RP-0976) was 30, 
40 and 17 years, respectively. Night blindness was the first symptom followed by visual field 
loss and reduction of visual acuity for all patients. At the time of the last ophthalmologic 
examination, visual fields were symmetrically reduced from 30 to 10 degrees. The best 
corrected visual acuity (BCVA) ranged from 0.8 to 0.5. Posterior subcapsular cataract was 
found in all cases. Fundi showed the typical changes of RP with pale optic disc, narrowed 
vessels, and bone spicule pigmentation (Figure 2A). Full-field electroretinogram was 
nonrecordable or substantially reduced. The ophthalmologic data of the patients are summarized 
in Table 4.  
In order to discard any distinctive sign of FEVR an intravenous fluorescein angiography was 
performed in homozygous (Figure 2B) and heterozygous carriers (Figure S2). The IVFA for the 
II:1 (RP-0322) showed classic RP findings and also vitreous alterations in some areas, blurring 
the visibility of the fundus.. Her affected sibling showed poor pigmentation in a mottled ‘salt-
and-pepper-like’ pattern, especially in the midperiphery. Fluorescein enhancement along the 
inferior temporal arcades corresponds to retinal pigment epithelium (RPE) atrophy. Also, 
blurring of the fundus was found in some areas due to vitreous condensation. Similarly to the 
first family, IVFA of patient II:2 (RP-0976), carrying the missense p.Arg541Cys also showed 
typical RP fundus findings combined with vitreous condensations that clouds the visibility of 
the fundus (Figure 2). 
The asymptomatic heterozygous p.Arg541Cys carriers (III:1 and III:2) from family RP-0976 
were examined. No retinal vasculature abnormalities such as an avascular retina, neovascular 
membranes or tractional retinal detachments were observed in the retinal periphery on fundus, 
IVFA and OCT (Figure S2). 
Unfortunately, patients carrying heterozygous p.Gly492Arg and p.Gln583Lys variants were not 
available for performing additional ophthalmic examination. 
ZNF408 is expressed in human retina especially in both cone and rod photoreceptor cells 
ZNF408 is abundantly expressed in the human fetal eye as well as in the adult retina, suggesting 
that ZNF408 has an important role in eye development and visual function (7). However, its 
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expression at the protein level and its localization in the human retina have never been 
investigated. To shed light on these aspects, ZNF408 protein expression and its cellular 
distribution were assessed using Western blot and immunochemistry assays, respectively, on 
adult healthy human retina as well as in the 661W photoreceptor cell line. 
In the human retina, the outer nuclear layer (ONL), ganglion cell layer (GCL) and both outer 
and inner plexiform layer (OPL and IPL) showed immunoreactivity against ZNF408 antibodies 
(Figure 3A), being strongest at the ONL level.  
In this context, ZNF408 immunolabeling at the ONL level presented intense spots of 
immunoreactivity located around the nuclei of the photoreceptors (Figure 3A,B,F,G) and axon 
terminals (Figure 3A,B,G; arrows). Additionally, the ZNF408 immunostaining pattern exhibited 
a marked expression in a specific subtype of amacrine cell (Figure 3H) and a subtype of 
ganglion cell of big size, with label in  their entire length, including cell body, dendrites and 
axons (Figure 3A,B,I). In addition, ZNF408 immunoreactivity was found in dendrites located in 
the IPL and in some ganglion cell axons running under the ganglion cell bodies in the nerve 
fiber layer (NFL) (Figure 3I).  
To verify that the ZNF408 staining was located at the ONL in rod and cones and not in the 
Müller cells processes, we performed a double immunolabelling with anti-CRALBP antibodies, 
a specific marker of Müller cells that marks these cells from the outer limiting membrane to the 
inner limiting membrane, labeling also the RPE (Figure 3B). Müller cell bodies were located in 
the inner most layer in the INL and their external processes pass around the cell bodies of all 
retinal cells, from the outer to the inner limiting membrane (Figure 3B red). Double labeling 
with anti-CRALBP and anti-ZNF408 antibodies showed no colocalization (Figure 3B). Higher 
magnifications in Figures 4A-C (arrowheads) showed absence of this colocalization verifying 
thus that ZNF408 is located in cell bodies, cytoplasm and myoids of photoreceptor cells but not 
in Müller cells.  
A closer view of the ONL showed that both rods (Figure 3F arrowheads) and cones (Figure 
3G; arrowheads) photoreceptor cells presented ZNF408 immunoreactivity. At the OPL level rod 
spherules (Figure 3A,B,G; arrows) and cone pedicles (double arrows in Figures 3A,B,G and 4L) 
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were easy to identify. Additionally, a weaker staining was observed in the inner and outer 
segments (Figure 3A,G). To confirm these results, we performed double immunostaining using 
antibodies raised against recoverin that label cone or rod photoreceptors and some type of 
bipolar cells, and anti-ZNF408. In this context, it was shown (Figure 4D-F) colocalization of 
anti-ZNF408 and anti-recoverin in both, cone and rod photoreceptors. Immunoreactivity in rod 
myoids is sharply reduced at the OLM level (arrowheads in Figures 3A,B,F and 4A-C) and only 
a weak immunostaining was observed in rod and cone outer segments. Double immunolabeling 
with anti-rhodopsin antibodies, a specific marker for rod outer segments, showed colocalization 
with the weak anti-ZNF408 immunoreactivity at this level (Figure 4G-I). Cone photoreceptor 
cells exhibited a bright ZNF408 immunoreactivity in its cell bodies, myoids, axons and pedicles 
while ellipsoids and outer segments showed a lower immunostaining signal, as revealed the 
double immunolabeling against anti-cone arrestin (Figure 4J-L). 
As addressed before, ZNF408 is related with FEVR (7). Double immunolabeling using anti-
ZNF408 and anti-collagen IV, a specific marker of blood vessels wall, was performed. Figure 
4M-O showed ZNF408 positive cells into blood vessels, which are presumably endothelial cells 
(Figure 4M-O; insets). Additionally, an immunofluorescence dotted along the cross sections of 
blood vessels was observed (Figure 4M-O, arrows). These results corroborate the relationship 
found between ZNF408 protein and FEVR patients by Collin and colleagues, supporting thus 
the role of ZNF408 protein in the development and maintaining of retinal blood vessels.  
It is important to remark that the antibody ZNF408 specificity was confirmed by the lack of 
immunoreactivity in the retina when the antibody was previously preincubated with its blocking 
peptide (Figure 3C). 
On the other hand, we performed immunocytochemistry analysis in the mouse retinal 
photoreceptor-derived 661W cell line. In this context, the ZNF408 immunolabeling exhibited a 
nuclear and cytoplasmic punctate staining pattern (Figure 3D,E). It is important to highlight the 
ZNF408 staining in nuclei, as expected given that the ZNF408 gene encodes a transcription 
factor that harbors ten predicted C2H2-type finger binding domains thought to be implicated in 
DNA binding (7). In all cases, the staining pattern appeared in the areas of the nucleus 
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corresponding with the euchromatin fraction (Figure 3E). Interestingly, this nuclear distribution 
was also observed in the human retina as demonstrated in cones and rods (Figure 3F,G), 
neurons in the INL and ganglion cells (Figure 3A,I).  
The immunoblotting analysis revealed the presence in the human retina and in the 661W cell-
line samples of a prominent and specific immunoreactive band with an apparent molecular 
weight of approximately 67 kDa corresponding to the ZNF408 protein (Figure 3J). We 
confirmed the specificity of the antibody by verifying that preadsorption of the antibody with 
the immunogenic peptide interferes with the ZNF408 detection. The observed size which was 
lower than the predicted for the isoform encoded by the canonical ZNF408 transcript (78.439 
kDa) could be the result of a non-uniform binding of the negatively charged SDS to the protein 
due to its amino acid composition or the presence of a post-translational cleavage of canonical 
protein, among others. 
Partial mislocalization of WT ZNF408 in presence of mutant p.Arg541Cys protein 
Constructs of the wild-type (WT) and the p.His455Tyr mutant together result in mislocalization 
of the WT ZNF408 in the cytoplasm suggesting oligomerization of ZNF408 WT and mutant 
proteins (7). In order to probe the behavior of our arRP-associated p.Arg541Cys variant, similar 
ZNF408 WT and mutant cotransfection studies were performed. Constructs expressing N-
terminal HA-tagged fusion proteins of WT_ZNF408 or the ZNF408_p.Arg541Cys mutant were 
generated. The analysis of more than 100 cells by immunocytochemistry of transiently 
transfected COS-1 cells revealed that localization of WT is exclusively restricted to the nucleus. 
The p.Arg541Cys mutant ZNF408 also mainly localizes to the nucleus, but occasionally is also 
present in the cytoplasm of the transfected cells (Figure 5A,B). In both cases, the accumulation 
of both mutants in the cytoplasm were statistically significant. However, the p.Arg541Cys 
mutant did not show a statistically significant decrease in the amount of cells showing nuclear 
localization of the ZNF408 protein when compared to the p.His455Tyr mutant. Upon 
cotransfection analysis of GFP-tagged WT ZNF408 and HA-tagged p.Arg541Cys mutant 
ZNF408, in those cells where p.Arg541Cys ZNF408 is located in the cytoplasm, it appears to 
also result in mislocalization of the WT ZNF408 (Figure 5D). Although similar observations 
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were found with the p.His455Tyr mutant, the amount of mislocalized WT ZNF408 protein 
appears to be less compared to the FEVR-causing p.His455Tyr variant (Figure 5C,D).  
Discussion 
In this study, we combined homozygosity mapping and whole exome sequencing analysis to 
identify two novel homozygous mutations in ZNF408 in unrelated Spanish families affected 
with RP. Furthermore, our functional studies provide evidence for the first association of this 
gene with inherited Retinal Dystrophy to date. 
ZNF408 belongs to a large family of transcription factors characterized by an N-terminal a set 
domain and tandem C-terminal C2H2-type zinc fingers. This gene is highly expressed in human 
adult and fetal retinal tissues, as was shown by RT-PCR analysis (7), suggesting that ZNF408 
could have an important role in retina development and homeostasis.  
A heterozygous mutation in ZNF408 has been previously described as cause of FEVR. FEVR is 
a rare, autosomal dominant inherited disorder characterized by an incomplete vascularization of 
the peripheral retina and/or retinal blood vessel differentiation.  
However, the two RP families described herein did not show any evident sign of FEVR. 
Interestingly all affected members of both families presented some vitreous alterations but, the 
ZNF408-linked RP phenotype of our individuals is completely different from that of FEVR and 
thus represents a different clinical form caused by mutations in ZNF408. 
Previous studies have been described posterior vitreous detachment and other vitreous 
alterations, including fibrillary degenerations, floaters, cottonball-like condensations, non-
pigmentary and pigmentary particulation in RP patients (9-11). In our patients, the density of 
the vitreal alterations is higher to the previously described, blurring the fundus resembling the 
vitreoretinal dystrophies although the morphology is not exactly veils. Therefore, the 
homozygous mutations described seem to cause a consistent typical RP phenotype with minor 
vitreous abnormalities other than those found in FEVR patients.  
Strikingly, in the RP-0322 family, we have found a homozygous frameshift mutation that it is 
expected to truncate the ZNF408 protein at its N-terminal, and thus predicted to result in a 
complete loss-of-function of ZNF408. The identification of a homozygous likely pathogenic 
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missense variant in a second family strongly supports the implication of ZNF408 in retinal 
degeneration. Our data suggest that ZNF408 may have essential functions in maintenance of 
retinal homeostasis, in addition to its role in vasculature development.  
Since FEVR is inherited as an autosomal dominant manner and it is known that asymptomatic 
FEVR patients frequently have very early manifestation of the vitreoretinal findings on 
angiography (12), an exhaustive ophthalmic examination was performed to exclude any 
symptom of FEVR in heterozygous carriers of the missense variants found in this study. 
However, no vascular alterations were observed in the examined asymptomatic individuals. 
It is intriguing how different mutations in ZNF408 could cause distinctive phenotypes of retinal 
disease with clearly different pathogenic mechanisms and also unequivocal inheritance patterns, 
such as adFEVR and arRP.  
As previously described, the FEVR-associated p.His455Tyr variant could act as dominant-
negative mutation. However, although the partial retention of the WT_ZNF408 by the 
ZNF408_p.Arg541Cys mutant was shown, this is not enough to produce a dominant-negative 
effect suggesting different mutational mechanisms for these two variants. This hypothesis is 
also strongly supported by the absence of phenotypic alterations in heterozygous carriers of the 
p.Arg541Cys mutation, i.e. neither displaying features of arRP nor adFEVR. 
Zinc fingers are elements for DNA binding found in a high number of proteins which participate 
in a wide variety of cellular activities (13). The greater the number of finger domains, the higher 
versatility and the more fingers with specific affinity for different ligands in specific classes of 
proteins (14, 15). ZNF408 comprises ten of such domains that could have different and still 
unknown cellular functions in several parts of the organism. The presence of mutations in these 
different domains suggests these changes are altering the interaction of ZNF408 with specific 
targets, thereby resulting in the dysregulation of different target genes and subsequently are 
underlying either FEVR or RP. 
Although further studies are mandatory to elucidate the role of ZNF408 in the human retina, it is 
also important to highlight the ZNF408 staining pattern localizes in the dark areas of the nucleus 
corresponding with the euchromatin fraction supporting the hypothesis that ZNF408 encodes a 
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transcription factor widely expressed in the human retina. Mutations in other genes encoding 
transcription factors, such as the photoreceptor-specific nuclear receptor subfamily 2 group E 
member 3 (NR2E3) gene, which plays a critical role in the photoreceptor differentiation, have 
been associated with a variety of retinal dystrophies, such as RP, Goldman-Favre disease or 
Enhanced S-cone syndrome, and can display different clinical features and patterns of 
inheritance, including autosomal-dominant and autosomal recessive (16-19). 
Further studies on the identification of the transcriptional targets of ZNF408 could help us to 
highlight new genes implicated for retinal development that could be good candidates for RD. 
Here, in order to identify the disease-causing gene in a Spanish family diagnosed with 
autosomal recessive RP (arRP), we have performed a combined approach including whole 
homozygosity mapping followed by a whole exome sequencing analysis (WES). The study 
revealed the presence of two novel different mutations in the ZNF408 gene in two unrelated 
arRP Spanish families and thereby expanding the spectrum of ZNF408 mutations to be 
associated with a new phenotype consisting of RP with vitreous condensations. 
Materials and Methods 
Patient Recruitment 
Patients diagnosed with RP were recruited from the Biobank of the Fundación Jiménez Díaz 
Hospital (Madrid, Spain). Diagnostic criteria of RP included night blindness and/or peripheral 
visual loss, with visual field loss and poor visual acuity in advanced stages of the disease. A 
commercial arRP genotyping microarray v2.0 (AsperBiotech, Tartu, Estonia) was used in the 
index cases to discard known mutations (20). A total of 218 unrelated Spanish families with 
autosomal recessive or sporadic RP were selected. Informed consent was obtained from all 
patients and family members or their legal guardians involved in the study. All procedures were 
reviewed and approved by the Ethics Committee of the Hospital and adhered to the tenets of the 
Declaration of Helsinki (Fortaleza 2013). 
One hundred and eighty seven unrelated individuals of Spanish origin without RP family history 
were screened as controls to evaluate the frequency of the missense mutation found in this study. 
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Peripheral blood samples from all participating individuals were collected in EDTA tubes. 
Genomic DNA was extracted with an automated DNA extractor (model BioRobotEZ1; 
QIAGEN, Hilden, Germany) following the manufacturer’s instructions. 
Genetic Analysis 
Homozygosity mapping 
A whole-genome homozygosity mapping was performed using Affymetrix 6.0 genotyping 
arrays (Affymetrix, Inc, Santa Clara, CA). Arrays were processed according to manufacturer’s 
protocols by the Spanish Center for Genotyping (CEGEN, Santiago de Compostela, Spain). 
Homozygosity regions were calculated using the Linkage Disequilibrium–Hidden Markov 
Model algorithm (21) through the dCHIP software (22). Regions with a size >1Mb were 
considered candidate regions to harbour the genetic defect. 
Next Generation Sequencing (NGS) 
Whole-exome sequencing (WES) analysis was performed by the Spanish Centre for Genome 
Analysis (CNAG, Barcelona, Spain). The SureSelect Human All Exon Version 4 kit (Agilent 
Technologies, Santa Clara, CA, USA) was used for in-solution enrichment of coding exons and 
flanking intronic sequences following the manufacturer’s standard protocol. Sequencing was 
done with an Illumina HiSeq2000 sequencing platform (Illumina) generating paired-end reads 
up to 100 cycles. 
Base calling and quality control were performed using the Illumina RTA sequence analysis 
pipeline. Bioinformatic analysis of the sequencing data was done by the Bioinformatic Platform 
for Rare Diseases (CIBERER-BIER, http://www.ciberer.es/bier/), using standard tools for 
quality control, sequence alignment, and variant calling in combination with our own in-house 
scripts including that of single nucleotide variants (SNVs) and small indels (23). 
Sanger sequencing analysis 
Bidirectional automatic sequencing was performed in order to confirm and segregate the 
obtained results by whole exome sequencing, also to screen the ZNF408 gene in 217 additional 
arRP families, and to determine the frequency of one of the missense variations in the control 
population. Exons and exon-intron boundaries of the ZNF408 gene (NM_024741.2) were 
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analyzed using 8 oligonucleotide primers pairs designed using Primer3 software. Sequences and 
annealing temperatures are available on request. The PCR products were enzymatically purified 
with ExoSAP-it (USB, Affymetrix) and sequenced using Big Dye Terminator Cycle Sequencing 
Kit version 1.1 (Applied Biosystems, Carlsbad, CA). The PCR products were resolved on an 
automated sequencer (ABI 3130xl Genetic Analyzer, Applied Biosystems). 
Sequencing results were analyzed by using Staden Package 1.7.0 software by assembling and 
visualizing the aligned sequences of the exons. 
Prediction of the pathogenic effect of the variants 
Pathogenicity of this variant was firstly assessed by co-segregation with the disease in the 
family, by its absence in a total of 374 healthy control Spanish chromosomes and in SNP 
databases (1000g and EVS databases) and by bioinformatic prediction tools (SIFT, Polyphen2 
and align-GVGD) which classified this variant as most likely damaging and by the amino acid 
conservation across 5 orthologs of the ZNF408 protein belonging to different evolutionary 
branches. The Clustal Omega tool and the Jalview Alignment Editor program were used to 
analyze the multiple sequence alignments. 
Comparative Genomic Hybridization array (aCGH) 
The custom aCGH 8X60k using Agilent SurePrint G3 CGH was designed using the Agilent 
eArray website (https://earray.chem.agilent.com/earray/) with an average distribution of 1 probe 
per 150pb in the ZNF508 gene.  
Briefly, genomic DNA (200ŋg) from the patient and from a sex-matched control were digested 
by Alu I and Rsa I restriction enzymes for 2 h at 37°C and the digested products were labeled 
with Cy3-dUTP and Cy5-dUTP fluorochromes using the Sure Tag DNA Labeling Kit (Agilent 
Technologies). The labeled products were purified, hybridized and washed according to Agilent 
protocols. The slide was scanned on a SureScan G4900DA scanner (Agilent Technologies), and 
the resulting TIFF images were converted by the image conversion Feature Extraction software 
(Agilent Technologies). Results were analyzed by Agilent CytoGenomics software v.2.7 using 
default analysis method – CGH v2 with the ADM-2 aberration algorithm. 
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Ophthalmic examination 
Ophthalmic examinations were performed for all patients with mutations in ZNF408 and the 
available heterozygous carriers. The evaluation included visual acuity, intraocular pressure, 
ocular motility, pupillary reaction, biomicroscopic slit lamp examination and dilated fundus 
examination. Visual function was evaluated by static perimetry and Ganzfeld 
electroretinography according to the ISCEV (International Society for Clinical 
Electrophysiology of Vision) (24). An intravenous fluorescein angiography (IVFA) was 
performed. 
Immunohistochemistry 
The ZNF408 localization pattern was determined in cryo-fixed healthy adult human retina 
sections. They were immunostained at room temperature overnight with rabbit polyclonal 
antibodies to human ZNF408 from Santa Cruz Biotechnology (Santa Cruz, CA, USA; Catalog 
No. sc-134190) diluted at 1:50 in 0.1 M sodium phosphate buffer (pH 7.4), 0.5% Triton X-100 
in the presence or absence of blocking peptide (20:1 peptide: antibody ratio; LifeTein South 
Plainfield NJ, USA). Double immunocytochemistry with ZNF408 were performed using it in 
combination with: monoclonal mouse anti-rhodopsin (Millipore Temecula, CA, USA), goat 
anti–recoverin (Santa Cruz Biotechnology Inc. TX, USA), goat anti-colagen IV (Millopore 
Temecula, CA, USA) and monoclonal mouse anti-cone arrestin (Dr. MacLeish, Morehouse 
School of Medicine; Atlanta, GA, USA) (25, 26). In addition, the 661W photoreceptor cell-line 
was also probed with the ZNF408 antibodies. 
Furthermore, ZNF408 protein expression was assessed using Western blotting on adult healthy 
human retinas as well as in the 661W photoreceptor cell-line. Briefly, proteins were extracted 
and subjected to immunoblotting analysis. Proteins (40 μg/lane) were resolved by SDS-PAGE 
on 4–20% polyacrylamide-gradient gels and electrotransferred to Hybond-P PVDF membranes 
(GE Healthcare, Buckinghamshire, UK). These were probed at 4 °C overnight with the same 
ZNF408 antibodies used in immunocytochemistry assays at a 1:100 dilution in 25 mM Tris (pH 
8.0), 150 mM NaCl, 2.7 mM KCl (TBS) in the presence or absence of blocking peptide (10:1 
peptide: antibody ratio; LifeTein South Plainfield NJ, USA), or with mouse monoclonal 
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antibodies to rabbit muscle GAPDH at a 1:1,000 dilution (Millipore, Temecula, CA, USA; 
Catalog No. MAB374). Thereafter, the membranes were incubated at room temperature for 1 h 
with horseradish peroxidase-conjugated goat anti-rabbit or goat anti-mouse (Pierce, Rockford, 
IL, USA) IgG at a 1:20,000 dilution. Detection was performed by enhanced chemiluminescence 
using the SuperSignal West Dura system (Pierce).  
Transfection of COS-1 Cells 
Constructs expressing HA-tagged or eCFP-tagged WT and mutant ZNF408 were designed using 
the mammalian expression vector pcDNA3-HA/DEST or pcDNA3-eCFP/DEST, both driven by 
a cytomegalovirus (CMV) promoter. 
COS-1 cells where transiently transfected using Effectene (Qiagen) according to the 
manufacturer´s instructions. In both cases, unpaired Student’s t-test as well as Mann-Whitney 
analyses were used to determine if there were statistically significant differences. Images were 
obtained with a Zeiss AxioImager Z1 upright fluorescent microscope and processed with a Zeiss 
ApoTome slider module. All experiments were performed in duplicate (7). 
Acknowledgments 
We would like to thank to FJD-Biobanco (RD09/0076/00101), Services of Genetics and 
Ophthalmology IIS-Fundacion Jimenez Diaz, (Madrid). CIBER-ER (06/07/0036), FIS 
(PI013/00226), Ministry of Economy and Competitiveness-FEDER (BFU2012-36845), and 
RETICS RD12/0034/0010), Miguel Servet CP/03256 (ISCIII), ONCE & Fundaluce for their 
support and to Spanish Center for Genotyping (CEGEN, Santiago de Compostela, Spain) for his 
contributions to this work. PC is supported by Fundación Conchita Rábago (FCR). dS is 
supported by CAPES Foundation, Ministry of Education of Brazil. 
This work is also supported by grants BIO2011-27069 from the Spanish Ministry of Economy 
and Competitiveness, and PROMETEOII/2014/025 from the Conselleria de Educacio of the 
Valencia Community.  
Conflict of Interest Statement 
The authors have no conflicts of interest to declare. 
 
 at U
niversidad de A
licante on A
pril 20, 2015
http://hm
g.oxfordjournals.org/
D
ow
nloaded from
 
17 
 
References 
1. Ayuso, C. and Millan, J.M. (2010) Retinitis pigmentosa and allied conditions today: a 
paradigm of translational research. Genome Med, 2, 34. 
2. Hartong, D.T., Berson, E.L. and Dryja, T.P. (2006) Retinitis pigmentosa. Lancet, 368, 
1795-809. 
3. Ayuso, C., Garcia-Sandoval, B., Najera, C., Valverde, D., Carballo, M. and Antinolo, G. 
(1995) Retinitis pigmentosa in Spain. The Spanish Multicentric and Multidisciplinary 
Group for Research into Retinitis Pigmentosa. Clin. Genet, 48, 120-2. 
4. den Hollander, A.I., Black, A., Bennett, J. and Cremers, F.P. (2010) Lighting a candle 
in the dark: advances in genetics and gene therapy of recessive retinal dystrophies. J. 
Clin. Invest, 120, 3042-53. 
5. Wright, A.F., Chakarova, C.F., Abd El-Aziz, M.M. and Bhattacharya, S.S. (2010) 
Photoreceptor degeneration: genetic and mechanistic dissection of a complex trait. Nat. 
Rev. Genet, 11, 273-84. 
6. Berger, W., Kloeckener-Gruissem, B. and Neidhardt, J. (2012) The molecular basis of 
human retinal and vitreoretinal diseases. Prog. Retin. Eye Res, 29, 335-75. 
7. Collin, R.W., Nikopoulos, K., Dona, M., Gilissen, C., Hoischen, A., Boonstra, F.N., 
Poulter, J.A., Kondo, H., Berger, W., Toomes, C. et al. (2013) ZNF408 is mutated in 
familial exudative vitreoretinopathy and is crucial for the development of zebrafish 
retinal vasculature. Proc. Natl. Acad. Sci. U S A, 110, 9856-61. 
8. Barragan, I., Borrego, S., Pieras, J.I., Gonzalez-del Pozo, M., Santoyo, J., Ayuso, C., 
Baiget, M., Millan, J.M., Mena, M., Abd El-Aziz, M.M. et al. (2010) Mutation 
spectrum of EYS in Spanish patients with autosomal recessive retinitis pigmentosa. 
Hum. Mutat, 31, E1772-800. 
9. Hikichi, T., Akiba, J. and Trempe, C.L. (1995) Prevalence of posterior vitreous 
detachment in retinitis pigmentosa. Ophthalmic Surg, 26, 34-8. 
 at U
niversidad de A
licante on A
pril 20, 2015
http://hm
g.oxfordjournals.org/
D
ow
nloaded from
 
18 
10. Vingolo, E.M., Giusti, C., Forte, R. and Onori, P. (1996) Vitreal alterations in retinitis 
pigmentosa: biomicroscopic appearance and statistical evaluation. Ophthalmologica, 
210, 104-7. 
11. Sudarshan, A.P. (1999) Vitreous change in retinitis pigmentosa. Ophthalmology, 106, 
210. 
12. Kashani, A.H., Learned, D., Nudleman, E., Drenser, K.A., Capone, A. and Trese, M.T. 
(2014) High prevalence of peripheral retinal vascular anomalies in family members of 
patients with familial exudative vitreoretinopathy. Ophthalmology, 121, 262-8. 
13. Pavletich, N.P. and Pabo, C.O. (1993) Crystal structure of a five-finger GLI-DNA 
complex: new perspectives on zinc fingers. Science, 261, 1701-7. 
14. Morgan, B., Sun, L., Avitahl, N., Andrikopoulos, K., Ikeda, T., Gonzales, E., Wu, P., 
Neben, S. and Georgopoulos, K. (1997) Aiolos, a lymphoid restricted transcription 
factor that interacts with Ikaros to regulate lymphocyte differentiation. EMBO J, 16, 
2004-13. 
15. Tsai, R.Y. and Reed, R.R. (1998) Identification of DNA recognition sequences and 
protein interaction domains of the multiple-Zn-finger protein Roaz. Mol. Cell Biol, 18, 
6447-56. 
16. Escher, P., Gouras, P., Roduit, R., Tiab, L., Bolay, S., Delarive, T., Chen, S., Tsai, C.C., 
Hayashi, M., Zernant, J. et al. (2009) Mutations in NR2E3 can cause dominant or 
recessive retinal degenerations in the same family. Hum. Mutat, 30, 342-51. 
17. Pachydaki, S.I., Klaver, C.C., Barbazetto, I.A., Roy, M.S., Gouras, P., Allikmets, R. and 
Yannuzzi, L.A. (2009) Phenotypic features of patients with NR2E3 mutations. Arch. 
Ophthalmol, 127, 71-5. 
18. Kanda, A. and Swaroop, A. (2009) A comprehensive analysis of sequence variants and 
putative disease-causing mutations in photoreceptor-specific nuclear receptor NR2E3. 
Mol. Vis, 15, 2174-84. 
19. Yang, Y., Zhang, X., Chen, L.J., Chiang, S.W., Tam, P.O., Lai, T.Y., Chan, C.K., Wang, 
N., Lam, D.S. and Pang, C.P. (2010) Association of NR2E3 but not NRL mutations 
 at U
niversidad de A
licante on A
pril 20, 2015
http://hm
g.oxfordjournals.org/
D
ow
nloaded from
 
19 
with retinitis pigmentosa in the Chinese population. Invest Ophthalmol. Vis. Sci, 51, 
2229-35. 
20. Avila-Fernandez, A., Cantalapiedra, D., Aller, E., Vallespin, E., Aguirre-Lamban, J., 
Blanco-Kelly, F., Corton, M., Riveiro-Alvarez, R., Allikmets, R., Trujillo-Tiebas, M.J. 
et al. (2010) Mutation analysis of 272 Spanish families affected by autosomal recessive 
retinitis pigmentosa using a genotyping microarray. Mol. Vis, 16, 2550-8. 
21. Beroukhim, R., Lin, M., Park, Y., Hao, K., Zhao, X., Garraway, L.A., Fox, E.A., 
Hochberg, E.P., Mellinghoff, I.K., Hofer, M.D. et al. (2006) Inferring loss-of-
heterozygosity from unpaired tumors using high-density oligonucleotide SNP arrays. 
PLoS Comput. Biol, 2, e41. 
22. Lin, M., Wei, L.J., Sellers, W.R., Lieberfarb, M., Wong, W.H. and Li, C. (2004) 
dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity 
data. Bioinformatics, 20, 1233-40. 
23. Aleman, A., Garcia-Garcia, F., Salavert, F., Medina, I. and Dopazo, J. (2014) A web-
based interactive framework to assist in the prioritization of disease candidate genes in 
whole-exome sequencing studies. Nucleic Acids Res, 42, W88-93. 
24. Marmor, M.F., Fulton, A.B., Holder, G.E., Miyake, Y., Brigell, M. and Bach, M. (2009) 
ISCEV Standard for full-field clinical electroretinography (2008 update). Doc. 
Ophthalmol, 118, 69-77. 
25. Martínez-Navarrete, G., Angulo, A., Martín-Nieto, J. and Cuenca, N. (2008) Gradual 
morphogenesis of retinal neurons in the peripheral retinal margin of adult monkeys and 
humans. J. Comp Neurol. , 511, 557-80. 
26. Fernandez-Bueno, I., Fernández-Sánchez, L., Gayoso, M., García-Gutierrez, M., Pastor, 
J. and Cuenca, N. (2012) Time course modifications in organotypic culture of human 
neuroretina. Exp. Eye Res., 104, 26-38. 
 
 
 at U
niversidad de A
licante on A
pril 20, 2015
http://hm
g.oxfordjournals.org/
D
ow
nloaded from
 
20 
Figure Legends 
Figure 1. A. Pedigrees of the two Spanish studied families with ZNF408 mutations. The index 
case is indicated with an arrow. Sanger sequencing confirms the mutations identified by WES 
and reveals their complete cosegregation with the disease. The chromatograms of a control and 
a homozygous individual with mutations are depicted for each variant (blue line). B. Schematic 
overview of ZNF408 taken and modified from Collin et al., The mutation previously associated 
with FEVR is shown in black. The mutations identified in this study and associated with RP are 
shown in red. C. Cross-species comparison of the region of ZNF408 indicates that the identified 
missense mutations affect a highly-conserved residues (red box).  
Figure 2. Phenotype of affected individuals with mutations in the ZNF408 gene. A. 
Spectrum of fundus findings in different individuals. Funduscopy of three patients (II.1 and II.2 
of the RP-0322 family and II.2 for the RP-0976 family) shows pale optic disc, attenuation of 
retinal vessels and bone spicule pigmentation. For the II.2 of the RP-0976 family it is also 
shown spotty pigmentation and peripapillary atrophy. Macular preservation is observed in all 
cases. B. Intravenous Fluorescein Angiography (IVFA) of the patients. For the patient II.1 of 
the RP-0322 the IVFA shows vitreous alterations blurring fundus in some areas (red arrows). 
The IVFA for the patient II.2 (RP-0322) shows fluorescein enhancement along the inferior 
arcades (blue arrow), poor pigmentation in mottled pattern in midperiphery and some areas with 
vitreous condensations (red arrows). For the individual II.2 of the RP-0976 family the IVFA 
shows typical RP fundus findings and also vitreous condensations blurring of the fundus in 
some areas (red arrows). C. Spectrum of optical coherence tomography (OCT) imaging in 
different individuals. 
Figure 3. Immunocytochemistry assays in cryofixed human retina sections and in the 
661W photoreceptor cell-line. A-C,F-H. Human retina immunolabeled with antibody against 
ZNF408 (green) and CRALBP (red). Nuclei are labelled with TO-PRO (blue). (A,B) ZNF408 
distribution in the ONL, OPL, IPL and GCL. (B) Double immunolabeling against CRALBP and 
ZNF408 antibodies showed no colocalization with Müller cells. (C) No immunofluorescence 
was detected in section using pre-adsorption with the blocking peptide. (F-G) High 
 at U
niversidad de A
licante on A
pril 20, 2015
http://hm
g.oxfordjournals.org/
D
ow
nloaded from
 
21 
magnification of photoreceptors showing immunoreactivity in both rods (F) and cones 
(arrowheads) (G). ZNF408 is expressed in cell bodies of some type of amacrine (H) and 
ganglion (I) cells and its dendrites in the IPL (A,B,H,I). Arrows in A,B,G indicates spherules of 
rods while double arrows in A,B,G indicates pedicles of cones. Arrowheads in A,B,G show 
ZNF408 immunolabeling at the border of the OLM. Arrows in F indicated the rod myoid and 
cell body.. (D, E) Nuclear and cytoplasmic ZNF408 immunoreactivity in the 661W 
photoreceptor cell-line. Note the ZNF408 localization in the less condensed chromatin areas. (J) 
Immunoblotting analysis of ZNF408 protein. Human retina (from two different individual, HR1 
and HR2) and 661W photoreceptor cell-line samples expressed strongly immunoreactive bands 
detected with ZNF408 or GAPDH antibodies (arrowheads). Protein molecular weight markers 
are given to the left. ZNF408 staining (peptide -) was specifically abolished when the ZNF408 
antibody was preincubated with its immunogen peptide (peptide +). Scale bar 
A,B,C,D,E,G,H=20um, F=10um. 
Figure 4. Immunocolocalization of ZNF408 in cryostat sections of human retina. Double 
immunolabeling of ZNF408 with antibodies against CRALBP, a specific marker for Müller 
cells and RPE (A,B,C); recoverin that labels cone and rod photoreceptors (D,E,F); rhodopsin, a 
marker for rod outer segments, (G,H,I) and cone arrestin that labels cone photoreceptors (J,K,L). 
Blood retinal vessels were labeled with anti-Collagen IV (M,N,O). No colocalization of ZNF408 
and Müller cells were found in the ONL (A-C, arrowheads). Photoreceptor cells labeled with 
recoverin antibody showed colocalization with ZNF408 in both cones and rods (D-F). ZNF408 
showed a weak immunolabeling in rod outer segments labeled with antibodies against 
rhodopsin (G-I). In addition, the double immunostaining with antibodies against arrestin showed 
a strong colocalization of ZNF408 in cones where it was located on cell bodies, axons and 
pedicles (double arrowheads), myoids and elipsoids (arrows), as well as a weak 
immunoreactivity was observed in the outer segments (arrowheads) (J-L). Antibodies against 
collagen IV immunolabeled the retinal blood vessels wall (N-O). ZNF408 immunopositive cells 
were present presumably in endothelial cells of the blood vessels (M-O, square), as well as 
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immunoreactive spots were found along blood vessels in horizontal sections (M-O, arrows). 
Scale bar = 20um. 
Figure 5. Immunocytochemical analysis. A. COS-1 cells transiently transfected with 
constructs encoding HA-tagged WT and mutant (p.His455Tyr, p.Arg541Cys) ZNF408 proteins. 
DAPI stains cell nuclei (top), whereas the anti-HA antibody stains the ZNF408 fusion proteins 
(middle). Merged pictures are shown on the bottom. Representative examples are shown for 
each transfection, indicating full nuclear localization for the WT, but with a partial cytoplasmic 
localization of the p.His455Tyr and p.Arg541Cys mutant ZNF408 proteins. B. Quantification 
by fluorescence microscopy. *Significant differences (p<0.0001). C-D Cotransfection analysis 
of WT and p.His455Tyr and p.Arg541Cys mutant ZNF408 proteins respectively DAPI stains 
cell nuclei (left), GFP stains ZNF408 WT and anti-HA stains ZNF408 mutants (middle) and on 
the right the merge pictures are showed.  
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Table 1. Homozygous regions shared by the two affected members of the RP-0322 family. 
Listed are homozygous regions > 1 Mb, sorted by size,  the start and the end position by hg19 of 
the regions, the size and the number of genes encompassed each regions. Chr: chromosome; 
Mb: megabases; No: Number. 
 
 
 
 
 
Ranking Chr Start position  End position Size (Mb) No. Genes 
1 11 44657924 47217647 2.6 59 
2 1 146198340 148529079 2.3 56 
3 7 116046131 118194089 2.1 17 
4 15 38922698 40687683 1.8 61 
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Table 2. WES findings. Overview of the number of the high-confident variants present, after 
applying all quality filters, in the index case (II.2) of the RP-0322.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
WES finding No. Variants 
Total 8133 
Potentially functional variants 7570 
Heterozygosis 3865 
Homozygosis 3705 
Effect 7570 
Non-synonymous SNV 7131 
Splicing 62 
Stop-gain SNV 55 
Stop-loss SNV 28 
Frameshift 187 
In-frame 107 
MAF<0,005 276 
Heterozygosis 150 
Homozygosis 126 
Variants in LOH 2 
Splicing 1 
Frameshift 1 
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Table 3. Pathogenicity assessment of ZNF408 missense changes. Assessment of pathogenicity for the ZNF408 missense changes. For Align GVGD, class 
C65 and C45 represent the highest and moderate, respectively, likelihood of a change to be pathogenic. 
  
Nucleotide change Amino acid change Frequency in 
ethnically matched 
control alleles 
Predictions of pathogenicity 
SIFT Polyphen2 Align GVGD 
c.1474G>A p.Gly492Arg 0/150 Deleterious Possibly 
damaging 
Class C65 
c.1621C>T p.Arg541Cys 0/374 Deleterious Possibly 
damaging 
Class C65 
c.1747C>A p.Gln583Lys 0/150 Deleterious Probably 
damaging 
Class C45 
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Table 4. Clinical features of patients with mutations in the ZNF408 gene.  ID, identification; YR, years; BCVA, best corrected visual acuity, RE, right eye; LE, left eye; ERG, electroretinogram; IVFA, intravenous fluorescein angiography; OCT, 
optical coherence tomography; NB, night blindness; VA visual acuity; RPE, retinal pigment epithelium; NCD, no clinical data. 
Family Patient  
ID 
Genotype First 
symptoms and 
course 
Age at 
diagnosis 
(yr) 
 
Age of 
Ophthalmic 
Evaluation 
(yr) 
BCVA 
RE/LE 
Visual  
Field 
RE/LE 
ERG Fundus 
aspect 
IVFA  OCT Additional  
findings 
Gene Mutations 
Allele1/Allele2 
   
RP-0322 
 
 
II:1 ZNF40
8 
p.Ala122Leufs*2/ 
p.Ala122Leufs*2 
NB (30yr), field 
constriction and 
progressive loss 
of VA 
52 69 0.5/0.8 Restricted to 
10º central 
field 
 
No register Pale optic disc, 
narrow 
vessels, 
moderate bone 
spicule 
pigmentation 
and RPE 
atrophy in mid 
periphery and 
macular 
preservation 
RP findings and 
vitreous alterations 
blurring fundus in 
some areas 
No liquid, 
perifoveal 
thinning, 
incipient 
epiretinal 
membrane 
Photophobia 
Posterior 
subcapsular 
cataract 
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II:2 ZNF40
8 
p.Ala122Leufs*2/ 
p.Ala122Leufs*2 
NB (40yr), field 
constriction and 
progressive loss 
of VA 
50 
 
67 0.6/0.5 Restricted in 
superior and 
temporal 
hemifield/ 
Restricted to 
30º central 
field 
inferonasally 
 
Rods 
abolished 
Mixed, cones 
and flicker 
diminished 
Normal optic 
disc, mildly 
attenuated 
vessels and 
poor 
pigmentation 
in lower 
hemiretina, 
macular 
preservation 
Poor pigmentation 
in mottled pattern 
specially in 
midperiphery. 
Fluorescein 
enhancement 
along the inferior 
temporal arcades. 
Blurring of the 
fundus due to 
vitreous 
condensation  
Normal 
morphology
,no cysts, 
incipient 
epiretinal 
membrane 
LE 
Photophobia 
Posterior 
subcapsular 
cataract 
 
RP-0976 II:2 ZNF40
8 
p.Arg541Cys/p.Arg541Cys NB, field 
constriction 
(17yr) and 
progressive loss 
of VA (36yr) 
20 50 0.8/0.9 Restricted to 
10º central 
field 
 
NCD Pale optic disc, 
peripapillary 
atrophy, vessel 
attenuation, 
both spotty 
and spicule 
pigmentation 
midperiphery, 
atrophy of the 
RPE and 
macular 
Typical RP fundus 
findings combined 
with vitreous 
condensations 
make difficult the 
visibility of the 
fundus 
Normal 
morphology 
in the fovea, 
no cysts, 
atrophy in 
the 
periphery 
 
Photosensitivity 
Posterior 
subcapsular 
cataract 
High myopia 
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preservation 
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AB
RP-0322
m: c.358_359delGT; p.Ala122Leufs*2
Homozygous
Control
m/mm/m
I:1 I:2
II:1 II:2
C
I:1 I:2
II:1 II:2 II:3
III:1 III:2
RP-0976
m: c.1621C>T p.Arg541Cys
+/+ m/m
Homozygous
Control
m/+
Human
Dog
Mouse
Frog
Zebrafish
Human
Dog
Mouse
Frog
Zebrafish
p.Arg541Cys
p.Gly492Arg
p.Gln583Lys
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A. Fundus
II.2
RP-0976
II.2
C. OCT
II.1
RP-0322
B. IVFA
II.2
RP-0976
II.2II.1
RP-0322
II.2
RP-0976
II.2II.1
RP-0322
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